Commentary. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
Samson
Russell
R
Mote Vascular Foundation, Sarasota, FL 34233, USA. Rsamson@veinandarteries.com